Galanin receptor 3
Galanin receptor 3 (GALR3) is a G protein-coupled receptor that in humans is encoded by the GALR3 gene. It is one of the three known receptors of the neuropeptide galanin.
Function[edit]
Galanin receptor 3 is a member of the galanin family of G protein-coupled receptors, which also includes GALR1 and GALR2. These receptors are activated by the neuropeptide galanin and have been implicated in a variety of biological processes, including pain perception, memory and learning, neuroendocrine regulation, and depression.
Gene[edit]
The GALR3 gene is located on the chromosome 22 at position 22q13.1. It spans approximately 5.5 kilobases and consists of three exons. The gene is expressed in various tissues, including the brain, pituitary gland, small intestine, and colon.
Clinical significance[edit]
Alterations in the function of the galanin system, including GALR3, have been implicated in several neurological disorders, such as Alzheimer's disease, epilepsy, and depression. In addition, galanin and its receptors are involved in the regulation of food intake, and alterations in their function may contribute to obesity and type 2 diabetes.
Pharmacology[edit]
Several drugs that target the galanin system, including GALR3, are under development for the treatment of various disorders, including depression, anxiety, Alzheimer's disease, and pain. These drugs include galanin agonists, which activate the galanin receptors, and galanin antagonists, which block their function.
See also[edit]
References[edit]
This GPCR-related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian